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1072Cardiac Imaging to Evaluate
Left Ventricular Diastolic FunctionABSTRACTLeft ventricular diastolic dysfunction in clinical practice is generally diagnosed by imaging. Recognition of heart
failure with preserved ejection fraction has increased interest in the detection and evaluation of this condition
and prompted an improved understanding of the strengths and weaknesses of different imaging modalities for
evaluating diastolic dysfunction. This review brieﬂy provides the pathophysiological background for current
clinical and experimental imaging parameters of diastolic dysfunction, discusses the merits of echocardiography
relative to other imaging modalities in diagnosing and grading diastolic dysfunction, summarizes lessons from
clinical trials that used parameters of diastolic function as an inclusion criterion or endpoint, and indicates
current areas of research. (J Am Coll Cardiol Img 2015;8:1071–93) © 2015 by the American College of Cardiology
Foundation.T he concept of left ventricular (LV) diastolicfunction as a characteristic separated fromsystolic function is not immediately com-
pelling. Classic functional diagrams of LV function,
like the pressure-volume loop, show a smooth
transition between systolic and diastolic pressure-
volume data. Furthermore, the term function, al-
though appealing for the pump action of the LV
in systole, seems less appropriate for the partially
passive ventricular ﬁlling phase changes in volume
and pressure. Nevertheless, the term diastolic func-
tion has become ﬁrmly rooted in cardiology and
denotes the ability of the LV to ﬁll sufﬁciently
to produce the requested stroke volume without
exceeding certain pressure limits during ﬁlling.
LV pressure during diastole is nearly identical to
left atrial (LA) and pulmonary capillary pressure
because the latter structures have an open commu-
nication with the LV during diastole. Increased
LA pressure implies pulmonary congestion, which
accounts for dyspnea in patients with left heart
failure. Clinical interest has been boosted by the
realization that about one-half of patients present-
ing with heart failure symptoms have a “pre-
served” LV ejection fraction (>50%), although at
closer inspection, systolic functional abnormalities
such as reduced longitudinal LV shortening are
often present. Hence, it has been assumed that a
large proportion of the “heart failure epidemic” is
primarily caused by diastolic LV dysfunction, and
this has been termed heart failure with preserved
ejection fraction (HFpEF). However, because symp-
toms of heart failure, in particular dyspnea, are not
always cardiac in origin, direct evidence of such
diastolic dysfunction should be sought beforesettling on the diagnosis of diastolic dysfunction
to explain HFpEF. Alternative diagnoses include
noncardiac disorders such as pulmonary disease
and obesity. Furthermore, valvular disease, such
as mitral stenosis, constrictive pericarditis, congen-
ital heart disease, pulmonary arterial hypertension,
and others, may cause HFpEF and should be
ruled out. Because exertional dyspnea is a common
symptom of coronary artery disease, this disease
also needs to be considered. Direct evidence of
diastolic LV dysfunction can be provided by inva-
sive measurements (LV pressure tracings or ideally
pressure-volume data), natriuretic peptide levels
indicating myocardial stretch, or cardiac imaging—
ﬁrst and foremost, echocardiography (1). Imaging
techniques, however, lack the capability of directly
measuring pressures, although they can measure
volumes and blood and tissue velocities; there-
fore, by nature, they only provide indirect
evidence of diastolic pressures or pressure-volume
relationships.
Like in any other diagnostic work-up, a clinical
question should always be the starting point. Reasons
for referring patients for evaluation of diastolic
function include: 1) symptoms or signs of heart failure
in patients with preserved LV ejection fraction; 2) the
need for an estimate of LV ﬁlling pressure in patients
with known heart disease; and 3) assessment of car-
diovascular risk.
In the following, we will review current knowledge
on how to assess diastolic LV function by cardiac
imaging, how well validated such assessment is, and
which prognostic implications these data have. We
will also describe the most important current open
questions and unmet needs.
AB BR E V I A T I O N S
AND ACRONYM S
AV = atrioventricular
CMR = cardiac magnetic
resonance
CT = computed tomography
e0 = left ventricular regional
lengthening velocity, usually
the septal or lateral basal LV
tissue velocity, also called
mitral annular velocity
e0sr = early diastolic strain rate
HFpEF = heart failure with
preserved ejection fraction
IVRsr = strain rate during
isovolumic relaxation time
LA = left atrium/atrial
LV = left ventricle/ventricular
LVEDP = left ventricular end-
diastolic pressure
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1073DIASTOLIC LV FUNCTION: A BRIEF SUMMARY
OF PHYSIOLOGY AND ITS REFLECTION IN
ECHOCARDIOGRAPHIC PARAMETERS
Whereas LV systolic function is routinely quantiﬁed by
measuring ejection fraction or deformation parame-
ters such as global longitudinal strain, there is no single
clinical measure that quantiﬁes LV diastolic function;
instead, a large number of indexes based on cardiac
imaging have been introduced.
The physiological hallmarks of LV diastolic
dysfunction are impaired relaxation, loss of restoring
forces, reduced diastolic compliance, and elevated LV
ﬁlling pressure. The latter is not a primary disturbance
of ventricular function but is a compensatory mecha-
nism to maintain LV ﬁlling and stroke volume (2).
In some patients, elevated ﬁlling pressure is observed
only during exercise; therefore, normal ﬁlling pressure
at rest does not exclude clinically signiﬁcant diastolic
dysfunction or HFpEF (3,4). There is no single non-
invasive index that provides a direct measure of
relaxation, restoring forces, compliance, or LV ﬁlling
pressure. However, by using a combination of different
noninvasive indexes, it is feasible in most patients to
determine if diastolic function is normal or impaired
(Central Illustration).
In addition, structural changes (e.g., LV hypertro-
phy) can indicate abnormalities of diastole and should
be considered.
INDEXES OF RELAXATION AND RESTORING FORCES.
Slowing of LV relaxation and loss of restoring forces
leads to reductions in velocities of LV lengthening and
untwisting and reduces the decay rate of LV pressure
during isovolumic relaxation. The latter response can
be measured invasively by micromanometer as pro-
longation of the time constant tau of LV pressure fall.
LV regional lengthening velocity (e0), however, can be
measured noninvasively by tissue Doppler imaging
and is a key parameter of diastolic function because it
reﬂects relaxation as well as restoring forces (5,6)
(Figure 1). It is inversely related to the relaxation
constant tau. Similar to most other parameters of LV
function, e0 is modiﬁed by diastolic pressure, but in
the failing heart, e0 is less load dependent than
transmitral velocities (7). Furthermore, if LV relaxa-
tion is slowed, e0 onset and peak, which normally
occur close to onset and peak of the transmitral E
wave, are delayed, leading to less dependence of e0
on LA pressure (8). Table 1 shows normal reference
values for e0.
LV early diastolic strain rate provides similar diag-
nostic information as e0 and can technically be derived
from speckle tracking–based strain imaging, althoughthe comparatively low achievable frame rates
make substantial information loss likely.
Although it is independent of cardiac trans-
lational motion, less angle dependent, and
less affected by tethering from neighboring
segments than velocities by tissue Doppler
imaging, it presently must be seen as an
experimental parameter of relaxation (9).
Similar to e0, LV untwisting velocity is deter-
mined by LV relaxation and restoring forces
and has the potential to become an important
measure of diastolic function (10,11). Due to
methodological challenges, however, assess-
ment of untwisting velocity is not recom-
mended for routine clinical examinations at
the present time (9,10).
Because restoring forces are created by
systolic contraction, both e0 and untwisting
velocity are determined in part by systolic
function (12,13), reﬂecting the tight coupling
between systolic and diastolic function.
There is no clinical method that differentiates be-
tween myocardial relaxation and restoring forces. In
heart failure, both mechanisms are affected and
contribute to slowing of LV isovolumic pressure fall
and elevation of minimal LV diastolic pressure.
Restoring forces may play a unique role by creating
negative LV diastolic pressure, which represents the
driving force for diastolic suction (13,14). Restoring
forces are generated in systole by a complex set of
mechanisms (15). A key element is storage of energy
due to contraction of myocytes and ventricles below
resting length (unstressed dimension), and analogous
to a compressed elastic spring, themyocardium recoils
in early diastole when the ventricle relaxes. Due to
ventricular ﬁlling, the negative pressures that result
from restoring forces may not be observed clinically
when LV pressure is recorded, and there is no easy
noninvasive method to measure diastolic suction.
Rapid early diastolic mitral-to-apical ﬂow propagation
has been proposed as amarker of diastolic suction (16).
In ventricles with increased end-systolic volumes,
restoring forces are attenuated or lost, as indicated by
elevation of minimal LV diastolic pressure, and my-
ocardial relaxation becomes an increasingly impor-
tant determinant of e0.
Mitralﬂowvelocities andﬁlling patternsmay also be
used to evaluate LV relaxation. Reduced decay rate of
LV pressure due to slowing of relaxation and loss of
restoring forces leads to elevation of minimal LV
pressure and therefore a reduction in the early dia-
stolic transmitral pressure gradient and the early
transmitral velocity (E) and a compensatory increase in
the A wave. The result is a reduction in the E/A ratio
CENTRAL ILLUSTRATION Schematic Drawing of Diastolic LV Filling
Diastolic left ventricular (LV) ﬁlling is shown with simultaneous recordings of left atrial (LA) and LV pressures, the diastolic transmitral pressure gradient, pulmonary
venous, transmitral, and transtricuspid ﬂow velocity, and septal tissue (or mitral annular) velocity. Flow velocity and tissue velocity data, together with LA size and
systolic pulmonary pressure, are used in echocardiography to infer diastolic LV pressures and hence diastolic LV function.
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1074along with prolongation of the deceleration time of
E, and thisﬁlling pattern is named impaired relaxation.
With further progression of diastolic function, how-
ever, this feature may disappear due to compensatory
rise in LA pressure, which serves tomaintain LV ﬁlling,and result in a pattern named pseudonormal ﬁlling
with normal transmitral E/A ratio. In contrast to “true”
normal ﬁlling, there is typically an associated reduc-
tion in e0 and often a more marked pulmonary venous
reversed velocity during atrial contraction. Such
TABLE 1 Normal Values for e0 and E/e0
e0 , cm/s E/e0 Ratio
Women, <40 yrs 10.0–19.2 3.0–8.2
Women, 40–59 yrs 6.5–16.1 3.2–10.4
Women, $60 yrs 1.8–14.6 3.1–14.3
Women, overall 5.4–18.2 2.5–10.9
Men, <40 yrs 8.7–19.5 2.5–8.5
Men, 40–59 yrs 6.1–15.3 3.0–9.4
Men, $60 yrs 4.4–12.0 3.1–12.3
Men, overall 4.8–16.8 2.4–10.4
Normal reference ranges for left ventricular regional lengthening velocity (e0 ; by
pulse-wave Doppler) and E/e0 ratio (mean  2 SD) in 1,266 randomly selected
healthy individuals. Average values from all 4 left ventricular walls. The ﬁndings
were similar when e0 was calculated as an average of septal and lateral e0 . Modiﬁed
from Dalen et al. (114).
FIGURE 1 The 3 Independent Determinants of LV Early
Diastolic Lengthening Velocity
(Top) Active relaxation, a decay in active ﬁber force by reduction
of actin-myosin interaction as cytosolic calcium is taken up by the
sarcoplasmic reticulum. (Middle) Restoring forces represent
passive elastic recoil, which occurs during left ventricular (LV)
relaxation and causes the ventricle to return to its resting posi-
tion. Restoring forces are the result of systolic contraction to
myocardial dimensions less than resting length (L0). The
magnitude of restoring forces varies inversely with minimal
length (Lmin). In the normal LV, restoring forces result in negative
early diastolic pressure, which sucks blood into the ventricle.
During heart failure, when the LV does not contract below L0,
restoring forces are lost and there is a loss of diastolic suction
and secondarily reduction in early diastolic lengthening velocity
(e0). (Bottom) Left atrial (LA) pressure at the onset of ﬁlling
determines the force with which the blood ﬁlls the LV and causes
it to lengthen. AO ¼ aorta. Modiﬁed, with permission from
Smiseth et al. (115).
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1075pseudonormalization due to increasing LA pressures
generated by advanced disease also occurs with other
blood ﬂow–based parameters like isovolumic relaxa-
tion time, E-wave deceleration time, and pulmonary
venous diastolic ﬂow, and constitutes a fundamental
problem in the assessment of diastolic function. In
summary, impairment of early diastolic function due
to slowing of relaxation and loss of restoring forces can
be detected noninvasively in clinical routine practice
as reduction in e0 and as a transmitral ﬁlling pattern of
impaired relaxation (Figure 2). Due to age dependency
of both parameters, it is important to use age-adjusted
reference values (Table 1).INDEXES OF REDUCED DIASTOLIC COMPLIANCE. LV dia-
stolic compliance is the relationship between change
in LV volume and change in pressure in diastole, or the
local slope of the pressure-volume relationship. It is
determined by LV myocardial compliance and by
elastic properties of extraventricular structures (i.e.,
pericardium and lungs) and by right ventricular pres-
sure. Because the LV pressure-volume relationship
does not reﬂect myocardial compliance, the term
chamber compliance is often used. Importantly, be-
cause the LV pressure-volume relationship is cur-
vilinear, chamber compliance is a function of the
operative LV diastolic pressure and consequently is
markedly load dependent. Therefore, a change in LV
chamber compliance does not necessarily mean there
has been a change in myocardial elastic properties, it
may just be a change in loading conditions that moves
the pressure-volume coordinate to a part of the curve
that has a different slope. There is no noninvasive
method that measures diastolic compliance, but
there are indexes that are related to LV compliance.
There is an association between reduced LV diastolic
compliance and short E-wave deceleration time (17–
19). Values <150 ms are consistent with reduction in
LV diastolic compliance in particular when there is
also a mitral ﬁlling pattern of restrictive physiology
(tall E and high E/A ratio). The relationship between
E-wave deceleration time and compliance is consistent
with theoretical predictions (18–20) (Figure 3). An
additional feature of this ﬁlling pattern is abbreviated
isovolumic relaxation time due to premature opening
of themitral valve caused by elevated LA pressure (21).
Importantly, the relationship between E-wave decel-
eration time and degree of diastolic dysfunction is
nonlinear; therefore, in mild diastolic dysfunction
dominated by impaired relaxation, there is prolonga-
tion of E-wave deceleration time because of ongoing
relaxation during ﬂow deceleration. Furthermore, in
FIGURE 2 Extreme Example of “Impaired Relaxation”
Pattern in a Patient With Hypertrophic Cardiomyopathy
(Top) Transmitral ﬂow pattern with near-absent E wave despite
sinus rhythm and normal heart rate. (Bottom) Tissue Doppler
recording from the septum with very low early diastolic
lengthening velocity.
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1076young healthy individuals with a highmitral E, there is
often a deceleration time of <150 ms (22). Therefore, a
short deceleration time should not be used as a stand-
alone index of reduced LV compliance. Reduction in
LV chamber compliance is also reﬂected in attenuation
and abbreviation of the transmitral A velocity (23) and
is typically combined with accentuation and prolon-
gation of the pulmonary vein reversed A velocity
(24,25). When LV compliance is reduced, a small
change in volume results in a large change in pressure;
therefore, atrial contraction results in a more marked
increase in LV pressure. When the atrium contracts
against a ventricle with reduced compliance, little
blood moves forward across the mitral valve, ante-
grade mitral ﬂow is interrupted prematurely, andinstead blood regurgitates into the more compliant
pulmonary veins. In the early phase of diastolic dys-
function and with a well-functioning LA, there may
be a relatively normal LV pre–A-wave pressure and a
marked rise in LV pressure during vigorous atrial
contraction, particularly when there is reduced LV
compliance. Low amplitude and short duration of the
transmitral A velocity in combination with a high
amplitude and long duration of the reverse pulmonary
venous velocity are typical for a ventricle with re-
duced chamber compliance and elevated end-diastolic
pressure (23–26).
Limitations of the difference in A-wave duration as
an index of diastolic compliance include atrial me-
chanical failure and problems with the quality of the
pulmonary venous ﬂow signal. Furthermore, reverse
A may be shortened in tachycardia and when the PR
interval is prolonged due to atrioventricular (AV)
block I or if there is signiﬁcant antegrade pulmonary
venous ﬂow at the time of atrial contraction, reﬂect-
ing the effect of blood inertia. In these cases, the
relation of the difference in A duration between
mitral and pulmonary venous ﬂow has less predictive
value for an increase in diastolic pressures.
Thus, a short E-wave deceleration time together
with a small and abbreviated mitral A and a large
reverse A of long duration are consistent with reduced
LV compliance.
ECHOCARDIOGRAPHIC DETECTION OF
ELEVATED LV FILLING PRESSURES IN
CLINICAL PRACTICE
LV ﬁlling pressure is invasively measured as left ven-
tricular end-diastolic pressure (LVEDP) or as pulmo-
nary capillary wedge pressure as an indirect measure
of mean LA pressure. There is often a slight difference
between the 2, but this is rarely of clinical signiﬁcance
as long as there is no mitral stenosis. Filling pressure is
considered elevated when the mean pulmonary
capillary wedge pressure is >12 mm Hg or when the
LVEDP is >16 mm Hg (1).
Like all imaging modalities, echocardiography has
no direct way to measure pressures in the LV. Thus,
indirect signs of pathological pressure-volume re-
lationships in the LV during diastole must be relied
upon. Becausemitral ﬂow velocities are determined by
the transmitral pressure gradient, peak mitral E is a
valuable parameter in the estimation of LA pressure.
However, due to a relatively large volume of blood
contained within a normal mitral valve, a substantial
fraction of the transmitral pressure gradient is needed
to overcome inertia. Therefore, mitral velocity can-
not be converted to pressure difference using the
FIGURE 3 Flow From Chamber A to B Measured by Doppler Echocardiography
In a hydraulic model, the ﬂow from chamber A to B (arrow) was measured by Doppler echocardiography, mimicking transmitral ﬂow during
passive left ventricular ﬁlling. A reduction in compliance in the receiving chamber (B) by placement of a solid object that reduced chamber
compliance led to shorter Doppler deceleration time. Reproduced with permission from Flachskampf et al. (18).
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1077simpliﬁed Bernoulli equation, like in mitral stenosis,
and the real pressure gradient is larger than that pre-
dicted by the simpliﬁed Bernoulli equation. Never-
theless, peak transmitral ﬁlling rate correlates well
with the transmitral pressure gradient (27,28). An
important limitation of peak mitral E as an index of LA
pressure is that it reﬂects only the AV pressure differ-
ence. Because LA pressure is the sum of LV diastolic
pressure and the transmitral pressure difference,
elevated mitral E velocity alone is not sufﬁcient in-
formation to conclude that LA pressure is elevated.
Therefore, in normal hearts that have low or even
slightly negative early diastolic LV pressures, a tall
mitral E obviously does not imply a high LA pressure.
However, in ventricles with reduced ejection fraction
or when e0 is low, impaired relaxation, and therefore
elevated LV early diastolic pressure, can be expected.
This is why the combination of a tall E and a low e0 in-
dicates elevated LV diastolic pressure and is expressed
as a high E/e0 ratio. Because the normal range of e0
is wide, with values between approximately 5 and
18 cm/s (Table 1), it is obvious that the E/e0 ratio cannot
be an accurate index of LA pressure. When used in
combination with other indexes, however, it has
proven useful. Furthermore, an E/e0 ratio larger than 15
is generally abnormal, regardless of age, and is strong
evidence of diastolic dysfunction. Restrictive mitral
ﬁlling pattern with a tall peak E, short E-wave decel-
eration time, and small A wave is consistent withelevated LA pressure if e0 is reduced (Figure 4). As
indicated in Table 1, the lower normal limit for e0 is 6 to
6.5 cm/s for individuals under the age of 60 years. In
older individuals who are apparently healthy, even
lower values of e0 may be found, but this may reﬂect
impaired diastolic reserve with aging or undetected
coronary artery disease. Furthermore, if e0 exceeds 8
cm/s, reduced LV relaxation can be excluded and
further studies of diastolic function may not be
needed. One important exception are patients with
constrictive pericarditis, who often have a normal e0. In
addition, patients with signiﬁcant mitral regurgitation
tend to have elevated e0, and this should be kept in
mind when the ﬂow chart proposed in Figure 5 is used
to conclude that a patient has normal diastolic func-
tion. Because e0 is used as a parameter of global LV
diastolic physiology, but is measured locally, local
changes may inﬂuence e0 in a way not reﬂecting global
LV diastolic function. In particular, septal infarction,
ventricular pacing, mitral annular calciﬁcation, and
left bundle branch block may lead to low septal e0. In
these cases, e0 should be measured at the basal lateral
wall. In general, using an average value from septal
and lateral e0 measurements (which typically are
approximately 10% higher than septal e0 measure-
ments) has been recommended as a surrogate for
measuring e0 in all 6 walls; however, in some cases
(e.g., very dilated ventricles) it is nearly impossible to
correctly measure lateral longitudinal velocity, and
FIGURE 4 Typical Transmitral Restrictive Pattern
(Top) Patient with hypertension and severely depressed systolic and diastolic LV function. Note steep deceleration slope (dashed line), very
short E-wave deceleration time (102 ms), minimal A wave (E/A ratio ¼ 100/20), and very low septal tissue Doppler velocities both in systole
and diastole (e0, arrow), with E/e0 ratio ¼ 100/4 ¼ 25 (Bottom). Abbreviations as in Figure 1.
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1078the sample volume records a mix of longitudinal and
radial tissue velocities. In these cases, lateral e0 should
not be used.
Systolic pulmonary artery pressure calculated as the
sum of the estimated right atrial pressure and the
systolic tricuspid pressure gradient can be obtained in
most patients and is one of themost valuablemeasures
in the evaluation of LV diastolic function. Provided
there is no pulmonary arterial disease, an elevated
pulmonary artery pressure is strongly suggestive of
elevated LA pressure. Mitral regurgitation is another
possible cause of elevated pulmonary artery pressure
and needs to be considered.As explained in the section on indexes of diastolic
stiffness, the magnitudes and durations of the ante-
grade mitral A and the reversed pulmonary venous A
can be used to roughly estimate LVEDP. A reverse
pulmonary venous A wave >30 ms longer in duration
than the antegrade A wave is consistent with elevated
LVEDP (10).
Another measure from the pulmonary venous ﬂow
tracing is the ratio between peak systolic velocity and
peak diastolic velocity. A ratio of systolic to diastolic
peak velocity of <1 is consistent with, but not speciﬁc
for, elevated LV ﬁlling pressure (10); other conditions
associated with such a ratio are atrial ﬁbrillation,
FIGURE 5 Simpliﬁed Flow Chart for the Integrative Echocardiographic Evaluation of LV Diastolic Function
IF
LAVI < 34 mL/m2 AND
e’ sep > 8 cm/s AND
e’ lat > 10 cm/s
No Constrictive Pericarditis
Grade I
E/A < 0.8
dec. time > 200 ms
Avg E/e’ < 9
(Or Hypovolemia
without Diastolic
Dysfunction)
Grade II
E/A 0.8 – 1.5
dec. time 160 – 200 ms
Avg E/e’ 9 – 12
Grade III
E/A > 2
dec. time < 160 ms
Avg E/e’ > 12
IF
LAVI ≥ 34 mL/m2 AND
e’ sep ≤ 8 cm/s OR
e’ lat ≤ 10 cm/s
No Diastolic Dysfunction
Diastolic Dysfunction
If inconclusive, consider:
SPAP   , pulmonary venous S/D < 1, onset e’ later than onset E, LV wall hypertrophy, and other signs
Modiﬁed from current recommendations (10). Avg ¼ average (from basal septal and basal lateral LV wall); dec ¼ deceleration; lat ¼ lateral;
LAVI ¼ left atrial volume index; sep ¼ septal; SPAP ¼ systolic pulmonary artery pressure; other abbreviations as in Figure 1.
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1079mitral regurgitation, and hypernormal early diastolic
relaxation in young patients. Further signs of ele-
vated LA pressure include the occurrence of a trans-
mitral L wave (Figure 6), which is due to continuing
antegrade pulmonary venous ﬂow into late diastole
in the presence of delayed LV relaxation and a
later onset of e0 than E wave, indicating that mitral
ﬂow volume is “pushed” rather than “pulled” into
the LV.
LA volume can be measured by echocardiography
and reﬂects in part the cumulative effects of ﬁlling
pressures over time. Therefore, an enlarged LA is a
marker of elevated LA pressure and a small left
atrium suggests normal LA pressure. Importantly,
atrial volume is not an index of instantaneous pres-
sure because enlargement of the atrium takes time.
Furthermore, an enlarged atrium may persist long
after normalization of LA pressures. An upper normal
value of 34 ml/m2 is commonly used; a dilated LA
higher than this value may also be seen in young
healthy athletes and in patients with bradycardia,
anemia, and other high-output states; atrial arrhyth-
mias; and mitral valve disease (10). On the other
hand, mild diastolic dysfunction without substantialpressure elevation at rest may coexist with LA size in
the upper range of normal. Thus, LA volume should
not be used as a stand-alone parameter to rule in or
rule out diastolic dysfunction.
Current recommendations (10) can be summarized
as follows. Echocardiographic evaluation of LV ﬁlling
pressure should include estimation of pulmonary ar-
tery systolic pressure, peak mitral E, and E/e0 ratio.
Duration difference between antegrade and retrograde
A wave, LA volume, and E-wave deceleration time are
additional useful measures. The only parameter in this
list that provides a direct estimate of pressure is
the tricuspid regurgitation velocity. An advantage of
pulmonary artery systolic pressure and difference in
A-wave duration is that they are essentially age inde-
pendent, and this also applies to the E/e0 ratio, which
is <15 in healthy individuals. Except for estimated
pulmonary artery pressure from tricuspid regurgita-
tion velocity, all other indexes are predictive of LV
ﬁlling pressure due to associations and therefore need
to be interpreted with several limitations in mind. In
spite of this, when indexes are consistent, it is possible
inmost patients to concludewhether the level of ﬁlling
pressure is normal or elevated (Figure 5). In some
FIGURE 6 Transmitral L Wave
This is a sign of elevated LA and LV ﬁlling pressure caused by continuing mid to late pulmonary venous ﬂow. Abbreviations as in Figure 1.
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dexes; therefore, the noninvasive study becomes
inconclusive with regard to ﬁlling pressure. The diag-
nosis of diastolic dysfunction by echocardiography
has limited reliability in particular in the following
circumstances: rapidly changing hemodynamics
(29); presence of other local factors inﬂuencing e0
(infarction, bundle branch block, pacing); additional
substantial valvular heart disease (e.g., mitral regur-
gitation); mitral annular calciﬁcation, which may
reduce e0 and augment E; and initial stages of diastolic
dysfunction.
NEW ECHOCARDIOGRAPHIC TECHNIQUES
DIASTOLIC STRESS TEST. In some patients, LV diastolic
pressures are normal at rest but become abnormal
under exercise; this is opposed to the response of a
healthy LV to physical exercise, during which diastolic
pressures aremaintainedwithin normal ranges, in part
due to enhanced myocardial relaxation (shorter tau)
(30). Moreover, the invasive ﬁnding of elevated pul-
monary wedge pressure at rest or at exercise in pa-
tients with suspected HFpEF seems to identify sicker
patients with highermortality, as a retrospective study
suggested in 355 patients (31), with a 10-year mortality
rate of 7% for those with normal pulmonary wedge
pressure at rest and with exercise, 28% with elevation
of exercise pressures only, and 32% with elevation at
rest and with exercise (there was no difference in
ejection fraction in these groups). Therefore, acquiringechocardiographic data under or after physical stress
(treadmill or bicycle) is an attractive concept to un-
mask diastolic dysfunction absent at rest. The typical
echocardiographic parameters acquired during exer-
cise or immediately thereafter are the E/e0 ratio and
peak tricuspid regurgitant velocity. Because the test
is not primarily intended to provoke ischemia, it can
be kept to modest degrees of exertion, although the
test can also be integrated into a classic stress echo-
cardiographic examination investigating ischemia,
with minimal additional time and expense. If there is
E-A and e0-a0 fusion under exercise tachycardia, mea-
surement of the E/e0 ratio is performed after the heart
rate falls, taking advantage of the delayed normaliza-
tion of exercise-induced diastolic dysfunction after
termination of exercise compared with heart rate.
Published studies of this test have shown the
following. Increases in the E/e0 ratio and pulmonary
pressure, assessed by peak tricuspid regurgitant ve-
locity, occur in a subset of patients with suspected
stress-inducible diastolic LV dysfunction (4,32). The
frequency of exercise-inducible diastolic dysfunction
obviously depends on the selection of patients un-
dergoing the test; in 1 study of 559 patients under-
going stress echocardiography, it was 20% (32).
Interestingly, only 9% of patients with post-exercise
E/e0 ratio >13, which in this study was taken as evi-
dence of inducible diastolic dysfunction, also had
evidence of inducible ischemia by wall motion ab-
normality assessment. An increase in the E/e0 ratio
under physical exercise indicates a concomitant
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1081increase in LVEDP (33). Increases in the E/e0 ratio
indicate a worse prognosis (34,35).
However, many patients in whom such a dysfunc-
tion would be suspected (e.g., patients with LV hy-
pertrophy or multiple risk factors but no clear-cut
echocardiographic signs of diastolic dysfunction at
rest) have a normal diastolic stress test; although a
positive test does seem to identify diastolic dys-
function and impaired prognosis with high speciﬁcity
(4,34), the sensitivity and negative predictive value
of the diastolic stress test are less clear, largely due to
the difﬁculty in obtaining an independent standard
(i.e., pressure measurements) during exercise. In a
study with invasive hemodynamic validation, an ex-
ercise E/e0 ratio >13 had a sensitivity of 73% and a
speciﬁcity of 96% for an exercise LVEDP >15 mm Hg
(33). In 498 Korean patients with preserved ejection
fraction (34) who were speciﬁcally referred for a dia-
stolic stress test, mainly to evaluate unexplained
dyspnea on exertion or “LV functional reserve,”
171 (34%) developed exercise-induced pulmonary
hypertension, of whom only 49 (29%) developed an
E/e0 ratio >15 under exercise; this again conﬁrms the
apparent low sensitivity of the diastolic stress test for
inducible diastolic dysfunction. Exercise-induced
pulmonary hypertension had a distinctly worse out-
come if associated with E/e0 ratio >15, whereas the
outcome of patients with pulmonary hypertension
without E/e0 ratio elevation was similar to that of
patients without inducible pulmonary hypertension.
By study criteria, none of these patients had an
exercise-inducible ischemic wall motion response. In
an Australian study of 493 patients with an indication
for exercise stress echocardiography and preserved
ejection fraction, 436 patients had a normal E/e0 ratio
at rest, but only 41 (9%) developed an E/e0 ratio >13
with exercise (35), and there was no relationship be-
tween E/e0 ratio and the development of ischemia,
which occurred in more than one-half of the patients.
Follow-up over 1 year showed no cardiovascular
deaths, but there were more hospitalizations in the
group with exercise-inducible increases in E/e0 ratio
than in patients without such increases. Published
studies of the diastolic stress test have examined dif-
ferently selected groups of patients, which is evident
from the widely differing (between none and one-half
of patients) rates of exercise tests positive for ischemic
wall motion abnormalities. This adds to the uncer-
tainty regarding the diagnostic accuracy of the test.
STRAIN IMAGING. Longitudinal LV function has been
found to be reduced in patients with HFpEF. This has
been assessed both by tissue Doppler and speckle-
tracking strain imaging. A recent study comparinglongitudinal and circumferential global strain in pa-
tients with manifest HFpEF, patients with hyperten-
sion without heart failure, and control patients found
lower longitudinal and circumferential peak strain
in patients with HFpEF (36).
Strain rate during the isovolumic relaxation time
(IVRsr) or early diastolic strain rate (e0sr) (Figure 7),
derived from global longitudinal speckle-tracking
strain, recently were proposed as a better substitute
for e0 to estimate LV ﬁlling pressures (37). Although
E/IVRsr correlated better with ﬁlling pressures than
E/e0sr, both parameters are noisy and IVRsr is espe-
cially challenging to measure and thus is experimental
at best. Nevertheless, the parameter E/e0sr was shown
to contain independent prognostic information in a
large longitudinal study of 1,048 survivors of myocar-
dial infarction (38).
ECHOCARDIOGRAPHIC ASSESSMENT OF DIASTOLIC
FUNCTION DURING OR IMMEDIATELY AFTER ACUTE
ISCHEMIA. Echocardiographic signs of diastolic dys-
function typically do not imply acute myocardial
ischemia. However, during acute supply ischemia
(e.g., balloon inﬂation during coronary angioplasty),
an abrupt reduction in the transmitral ﬂow velocity
integral (affecting both E and A waves) is observed
(39,40). Further, diastolic tissue velocities decrease or
are even reversed in the ischemic region, and e0sr de-
creases drastically. These diastolic changes in defor-
mation during acute ischemia have been proposed as
markers of acute ischemia and have been shown to last
longer than wall motion abnormalities after reperfu-
sion. Ishii et al. (41) showed that delayed relaxation
could be detected using a radial myocardial strain
index during and up to 10 min after induction of
ischemia by treadmill stress echocardiography. In
more recent work (42), a modiﬁcation of this index,
now based on global longitudinal strain, was corre-
lated with simultaneous LV pre–A-wave pressure in
patients assessed for coronary disease; these patients,
however, did not have acute ischemia.
TORSION. The clinical evaluation of the twisting mo-
tion of the LV has become feasible as a by-product of
speckle tracking–based circumferential strain mea-
surements. Being largely still a research tool, there is
little standardization of measurements and even of
terminology. Recommendations from international
echocardiographic societies (9) deﬁne rotation as
rotational displacement around the long axis of the LV
(in degrees); twist as the net difference between (small)
rotation of the LV base and the larger rotation of
the apical portion of the LV (in degrees)—in systole,
the apex rotates counterclockwise (looking from
apex toward base) and the base clockwise; torsion as
FIGURE 7 Diastolic Strain Rate
Speckle tracking–based early diastolic longitudinal strain rate (red double arrow; 1/s) from the mid-septum (blue dot in left 4-chamber view) of
a patient with normal left ventricular function. AVC ¼ aortic valve closure.
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(in degrees/cm).
Animal studies (11) have shown that the peak LV
untwisting rate in early diastole is a marker of diastolic
function; the rate depends on LA pressure, active
myocardial relaxation, and elastic “restoring forces”
stored during the buildup of systolic twist. Twist and
torsion increase with LV hypertrophy (43), volume
loading (44), physical endurance training (45), and age
(43). However, the untwisting rate during isovolumic
relaxation reﬂects active relaxation and passive
restoring forces only, thus being largely load inde-
pendent, although not independent of systolic func-
tion because this feeds the passive restoring forces of
the LV (46). Peak untwisting rate, which occurs in early
diastole, has been calculated in healthy volunteers at
115  40/s, more than doubling during physical exer-
cise (45,47) and increasing after volume loading (44),
perhaps due to higher restoring forces built up by
higher previous systolic twist. Although hypertrophy,
due to hypertension or cardiomyopathy, leads to
higher twist, patients with hypertrophic cardiomyop-
athy (46) and patients with HFpEF have been reported
to have lower diastolic untwisting velocity (48)
(Figure 8). Thus, the loss of rapid untwisting, due to
decreased LV restoring forces, deprives the LV of its
early diastolic suctionmechanism, leads to an increasein LV diastolic pressures, and is a crucial event in the
evolution to heart failure symptoms. Published reports
are not entirely consistent, however, and increased
systolic twisting and diastolic untwisting rates were
observed in a group of patients with mild diastolic
dysfunction compared with healthy control patients,
potentially related to LV hypertrophy and smaller
end-systolic volumes in these patients (49).
In spite of their theoretical attractiveness, however,
these rotational events have very small amplitudes—in
healthy humans, peak LV twist has been estimated at
just 11 4 (47). Thus, the robustness of suchmeasures
in clinical practice remains to be determined.
DIASTOLICFUNCTIONASSESSEDBYECHOCARDIOGRAPHY
IN LARGE CLINICAL INTERVENTION TRIALS. Echocardio-
graphic measures in clinical trials can be used to
either select the eligible participants or evaluate the
treatment effect. Echocardiographic parameters of LV
diastolic function have not been used as vigorously
as systolic function measures for inclusion into clin-
ical trials or as surrogate endpoints in clinical thera-
peutic interventional trials. Several smaller phase II
clinical trials have used diastolic measures for par-
ticipant selection and/or assessment of treatment
effect. These trials have primarily focused on 2 dis-
ease categories, hypertension and HFpEF, in which
diastolic dysfunction is frequently present.
FIGURE 8 Left Ventricular Rotation
Rotation curve of patient with heart failure with preserved ejection fraction (left) and control patient (right) showing reduced magnitude of
peak apical rotation and percentage of early untwist (25% of total untwist duration), derived from speckle tracking 2-dimensional echocar-
diography. AVC ¼ aortic valve closure. Reproduced with permission from Tan et al. (48).
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1083USING DIASTOLIC ECHOCARDIOGRAPHIC PARAMETERS
IN PARTICIPANT SELECTION. Parameters of diastolic
function are strong predictors of future cardiovascu-
lar morbidity and mortality (50–54). Because diastolic
function is not evaluated by a single measure, but
through the interpretation of several echocardio-
graphic parameters, using diastolic function as an
entry criterion for trials generally requires sophisti-
cated interpretation of data and is best suited for a
core laboratory. The use of diastolic function as
a measure for entry has been minimal in trials of
HFpEF, despite HFpEF initially being called “diastolic
heart failure” (55–59). Diastolic echocardiographic
measures have been used in patient selection only in
smaller clinical trials (54,55). In the SIDAMI (Sildenaﬁl
and Diastolic Dysfunction After Acute Myocardial
Infarction) trial, the investigators hypothesized that
sildenaﬁl would reduce ﬁlling pressure during exer-
cise in patients with diastolic dysfunction after my-
ocardial infarction (60). The investigators used only
2 measures of diastolic function as inclusion criteria:
E/e0 ratio and LA volume index. Even so, they had to
screen approximately 1,300 patients by echocardiog-
raphy to identify approximately 300 patients with anE/e0 ratio $8 and an LA volume index $34 ml/m2. This
illustrates that the complexity of diastolic function
grading can make it challenging to identify appro-
priate candidates to include in trials.
In the Use of Exercise and Medical Therapies to
Improve Cardiac Function Among Patients With
Exertional Shortness of Breath Due to Lung Congestion
trial (59), the investigators were aware of the low
speciﬁcity of exertional shortness of breath to di-
agnose diastolic dysfunction. They sought to over-
come this problem by performing the evaluation of
diastolic dysfunction during exercise. The inves-
tigators therefore identiﬁed patients who had exer-
tional shortness of breath and a coherent increase in
the E/e0 ratio to >13. Again, however, due to the difﬁ-
culties cited in identifying patients with congruent
symptoms and echocardiographic parameters, the re-
searchers only randomized 61 patients in this trial.
USING DIASTOLIC ECHOCARDIOGRAPHIC MEASURES TO
ASSESS TREATMENT EFFECT. Evaluation of a possible
treatment effect with diastolic echocardiographic pa-
rameters has important limitations. Doppler velocity
curves, especially obtained from blood ﬂow, show
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with changes in afterload, pre-load, and sympathe-
tic tone. Additionally, they are highly susceptible to
spectral broadening of the time-velocity curve,making
it difﬁcult to accurately assess true peak velocities and
to identify small changes in diastolic function with
treatment. Further, there is considerable interob-
server and test-retest variability in diastolic echocar-
diographic parameters, necessitating relatively large
sample sizes to detect a treatment effect. Thus, echo-
cardiographic core laboratories are crucial to assess
diastolic echocardiographic parameters in multicenter
trials (61–63). Furthermore, even if a therapeutic
intervention leads to an improved diastolic function,
in the absence of clear-cut symptomatic or prognos-
tic clinical beneﬁt, the improvement in echocardio-
graphic parameters alone would not be sufﬁcient
evidence for drug or device approval. Moreover, some
measures are very age dependent (10,64,65). Hence,
for example, in the VALIDD (Valsartan in Diastolic
Dysfunction) trial, patients with diastolic dysfunction
based on lateral mitral e0 were enrolled—the exact
cutoff that allowed entry was dependent on patient
age (66). Furthermore, the U-shaped nature of the E/A
ratio, isovolumic relaxation time, and deceleration
time in the progression through the diastolic function
grades, with similar values seen in healthy individuals
and patients with cardiac disease, make it impossible
to assess the point in the progress of diastolic
dysfunction a speciﬁc participant is, if other diastolic
measures are not included in the assessment. Lastly,
sinus tachycardia and ﬁrst-degree AV block can result
in partial or complete fusion of the mitral E and A
waves, making it difﬁcult to assess the E/A ratio and
the deceleration time. These limitations make blood
ﬂow Doppler measures especially poor as surrogate
endpoints. On the other hand, e0, E/e0 ratio, and LA
volume incrementally change with worsening dia-
stolic function, making them easier to use as surrogate
diastolic endpoints in interventional trials.
Whereas Doppler velocities and time intervals
reﬂect ﬁlling pressures and diastolic relaxation at the
time of measurement, the LA volume reﬂects the cu-
mulative effects of diastolic dysfunction and increased
ﬁlling pressures over time and has been called the he-
moglobin A1c of diastolic function. Trials using this
marker as a surrogate endpoint should therefore be
planned for a sufﬁcient amount of time for the LA to
undergo remodeling to a smaller volume. This is
probably one of the reasons why most trials testing a
treatment of diastolic function have mainly focused
on e0 and/or the E/e0 ratio (59,66–68). In the PARA-
MOUNT (Prospective Comparison of the Angiotensin
Receptor Neprilysin Inhibitor With AngiotensinReceptor Blocker on Management of Heart Failure
With Preserved Ejection Fraction) trial (69), the
investigators assessed the effect of LCZ696 on echo-
cardiographic measures as secondary endpoints; the
primary endpoint was the change in the levels of N-
terminal pro–B-type natriuretic peptide (NT-proBNP).
The investigators found that the only echocardio-
graphic measure that improved, coherent with an
improvement in the levels of NT-proBNP, was LA size
(both deﬁned by the diameter and the volume). In
comparison, the authors found no change in e0 or the
E/e0 ratio. This emphasizes that LA size, which reﬂects
sustained increase in LVﬁlling pressure,may be amore
robust metric of diastolic function than Doppler-
derived measures, which are subject to greater vari-
ability and are more sensitive to changes in afterload,
pre-load, and sympathetic tone.
Recent studies have focused on assessing LA func-
tion instead of maximal size as a sensitive marker of
diastolic dysfunction and morbidity (70–72). Because
the LA is a thin-walled structure, continuously
exposed to LV pressure and function, it may provide
information on pre-clinical and early impairment of
the LV. Measures of LA function have been demon-
strated to identify minuscule impairment of LV func-
tion even when ejection fraction is normal (72) and to
identify patients with hidden paroxysmal atrial ﬁbril-
lation following a cryptogenic ischemic stroke as the
only echocardiographic parameter (70). However, in-
vestigators using LA measures of structure and func-
tion have to bear in mind that the pathophysiological
factors that affect function and maximal size are
different. Parameters of LA function (e.g., longitudinal
shortening, minimal size, emptying fraction) are
determined by LA contractility and the instantaneous
loading conditions, which strongly depend in turn
on LV properties and pulmonary vein compliance,
whereas the maximal LA size is a marker of chronic
pressure overload causedmainly by severe LVdiastolic
dysfunction.
LARGE INTERVENTION TRIALSASSESSING THE EFFECTOF
TREATMENT ON DIASTOLIC FUNCTION. Only a few large
interventional phase II trials have assessed the treat-
ment effect on diastolic dysfunction as a surrogate
primary endpoint. They generally fall into the category
of diastolic dysfunction due to hypertension (66,67) or
diastolic function in HFpEF (59,68). The aim of the
VALIDD trial was to determinewhether lowering blood
pressure with an angiotensin receptor blocker would
improve diastolic function to a greater extent than
would pharmacological approaches not based on in-
hibition of the renin-angiotensin-aldosterone axis.
The investigators found that lowering blood pressure
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1085improved diastolic function, deﬁned by an increase
in e0 at follow-up, irrespective of the type of antihy-
pertensive agent used (66). They also found that the
participants in the valsartan group improved the iso-
volumic relaxation time and longitudinal systolic peak
tissue velocity. Whether the improvement in early
relaxation was due to an actual improvement in the
diastolic function of the heart or due to decreased
afterload, which is well known to improve the rate of
early relaxation (73,74), remains unknown.
In the EXCEED (Exforge Intensive Control of Hy-
pertension to Evaluate Efﬁcacy in Diastolic Dysfunc-
tion) trial, the aim was to test whether intensive blood
pressure control among patients with uncontrolled
hypertension and diastolic dysfunctionwould bemore
effective in improving diastolic function than standard
blood pressure control (70). The investigators found
that the degree of blood pressure reduction observed
was the most important determinant of the degree
of improvement in diastolic function, determined
by e0. However, they found no difference in the im-
provement in e0 between the intensive blood pressure
treatment group and the standard blood pressure
treatment group. Isovolumic relaxation time was
the only diastolic measure that showed a statistically
signiﬁcant improvement in the intensive treatment
group compared with the standard treatment group,
which is comparable to the results of the VALIDD trial
(66). Again, whether these improvements in the dia-
stolic function actually represent improved diastolic
function or rather changes in the diastolic measures
accompanying decreased afterload is unclear.
The aim of the Aldo-DHF (Aldosterone Receptor
Blockade in Diastolic Heart Failure) trial was to eval-
uate the effect of spironolactone on diastolic function
and exercise capacity in patients with HFpEF (68). The
investigators found that spironolactone improved
diastolic function, as determined by the E/e0 ratio (and
natriuretic peptide levels). This improvement in
function (including e0, E, LV ejection fraction andmass
index, and LV end-diastolic diameter) was not associ-
ated with improvement in the maximal exercise ca-
pacity, patient symptoms, or quality of life. Again, as in
the VALIDD and EXCEED trials, the improvement in
the E/e0 ratio was accompanied by a highly signiﬁcant
reduction in blood pressure. However, the in-
vestigators demonstrated that after adjustment for
baseline and follow-up blood pressure values, the ef-
fects of spironolactone on diastolic function (E/e0 ratio)
remained statistically signiﬁcant, suggesting that the
reverse remodeling effects of spironolactone were in-
dependent of blood pressure reduction. Nevertheless,
blood pressure is only an indirect measure of LV
afterload, and correction for blood pressure reductionin the statistical model may not be adequate to refute a
primary effect of changes in loading conditions to
explain the differences seen between the 2 groups.
Additionally, even though spironolactone improved
an echocardiographic measure of diastolic function,
the TOPCAT (Treatment of Preserved Cardiac Function
Heart Failure With an Aldosterone Antagonist) trial
recently demonstrated no beneﬁt of spironolactone in
preventing adverse outcomes in HFpEF (75). In this
trial, the E/e0 ratio was among the strongest prognos-
ticators in patients with HFpEF, re-emphasizing the
importance of diastolic impairment in the progression
of the disease.
ASSESSMENT OF DIASTOLIC FUNCTION:
NUCLEAR IMAGING
From gated radionuclide ventriculography data, LV
ﬁlling rates can be calculated by comparing sequential
LV volumes during diastole, which can be calculated
with frame rates of approximately 20/s. From these,
time-volume ﬁlling curves, peak ﬁlling rates, and time
to peakﬁlling rates can be determined (Figure 9), which
decrease with slowed LV relaxation. Low time resolu-
tion and pre-load dependence of ﬁlling rates affect
their interpretation; thus, nuclear imaging is rarely
used to assess diastolic function.
ASSESSMENT OF DIASTOLIC FUNCTION:
CARDIAC MAGNETIC RESONANCE
Cardiac magnetic resonance (CMR) is generally regar-
ded as the gold standard for assessing the volume
of cardiac chambers and, as such, is well suited to
provide LV volume changes over time, which can be
converted to ﬁlling curves routinely by analysis
packages (Figure 9). Similar to the less accurate and
temporally coarser nuclear ventriculography data,
peak ﬁlling rates and time to peak ﬁlling are the
fundamental parameters. However, in a study exam-
ining the use of early and late LV peak ﬁlling rates
in assessing iron load in thalassemia, which can be
directly estimated by T2* CMR (76), these parameters
were not found to be useful. Blood ﬂow velocity can
be measured directly (i.e., not via volumetric ﬁlling
rates) by velocity encoding or “phase-contrast” CMR.
Hence, transmitral and pulmonary vein ﬂow can
be measured and used in a manner analogous to
echocardiographic Doppler values (77). In addition,
tissue velocity (e.g., of the ventricular walls) can be
measured, although only small validation studies
exist (78). Of course, CMR is also an established tech-
nique to measure LA volume (79); however, system-
atically and substantially higher LA volume values by
CMR than by echocardiography have to be taken into
FIGURE 9 Volume Curves From Cardiac Magnetic Resonance of the LV
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dictive value of CMR parameters of LA function (e.g.,
minimal volume or LA strain by CMR feature tracking)
and found predictive value of such measures for the
development of heart failure (80).
Strain, strain rate, and torsion can be extracted
from CMR data by 3 entirely different approaches:
1) tagging, in which material points in the myocardium
are marked by “nulling” the signal from these points
at baseline (e.g., in a grid pattern) and then following
these points in the myocardium over time (Figure 10);
2) feature tracking, which is akin to speckle trackingby echocardiography—this is a post-processing tech-
nique applied to CMR or computed tomography (CT)
images that primarily depends on the characteristics
of the images (e.g., contrast, noise), not the under-
lying imaging technique; and 3) velocity encoding
(or phase-contrast) CMR; this technique, which is
standard in CMR for blood ﬂow velocity measurement,
can be applied to tissue as well, analogous to tissue
Doppler imaging in echocardiography, and the data
can be processed to estimate strain (81).
Higher torsion by CMR has been found in women
and older individuals, which is ascribed to the
concomitant increase in concentric remodeling and
relative wall thickness (43). These researchers also
saw lower circumferential strain in older individuals.
The prognostic utility of CMR indexes of diastolic
strain was evaluated in a substudy from the MESA
(Multi-Ethnic Study of Atherosclerosis) project, a
large-scale prospective, population-based observa-
tional study (82). From CMR tagging, circumferential
LV strain and strain rate were calculated; in addition to
peak torsion rate and early diastolic circumferential
strain rate, a new index of relaxation analogous to the
isovolumic relaxation time was computed from these
curves in 1,544 patients. Although torsion rate and e0sr
were of no or little value, the new index predicted
(independently from clinical variables, ejection frac-
tion, and natriuretic peptide levels) the occurrence of
heart failure and/or atrial ﬁbrillation over a mean
follow-up of 8 years. Similar ﬁndings were reported
more than a decade agowith simple echocardiographic
measurements of LV systolic and diastolic function,
particularly peak E velocity (83). Similarly, a baseline
echocardiographic pattern of impaired relaxation,
combined with LA enlargement, was found to be pre-
dictive of heart failure or atrial ﬁbrillation during
follow-up (84).
Recently, in a small study of women with “signs
and symptoms” of ischemia but no epicardial coro-
nary stenosis, CMR was used to evaluate both systolic
and diastolic LV function by strain and torsion
(Figure 10). Although no differences in systolic strain
were found, peak (early) diastolic strain rate and peak
untwisting rate seemed to differentiate these “syn-
drome X” patients from healthy individuals (85).
An entirely different CMR-speciﬁc, albeit indirect,
way to assess diastolic function is based on the
concept of “T1 mapping,” which calculates T1 (or
longitudinal) proton relaxation times (in ms) after an
electromagnetic pulse and depicts them as pixel in-
tensity (86,87). Pathological changes of T1 times in
myocardial space may be due to excess water, iron, or
protein deposition. T1 mapping can be carried out
with or without gadolinium contrast (“native” T1
FIGURE 10 LV Circumferential and Torsional Strain Derived From CMR Tagging
(A) Representative cardiac magnetic resonance (CMR) image obtained at the level of the papillary muscles, with a tissue tagging sequence
(Top). Analysis was performed using commercially available software (HARP, Diagnosoft, Durham, North Carolina), which constructs a mesh
tracking tissue deformation over a single cardiac cycle, using the harmonic phase. (B) Representative tracing of circumferential strain (solid
line) and circumferential strain rate (dashed line) over a single cardiac cycle. (C) Representative data tracing of apical (red line) and basal (blue
line) rotation, net torsion (solid black line), and the rate of ventricular twisting (dashed line) over a single cardiac cycle. Reproduced with
permission from Nelson et al. (85).
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native T1 mapping encompasses both intracellular
and extracellular changes, the so-called extracellular
volume technique, which requires gadolinium-based
contrast application, allows quantiﬁcation of the ex-
tracellular volume fraction of myocardium, which is a
surrogate for myocardial ﬁbrosis, interstitial edema,
and others (Figure 11). Different than late enhance-
ment after gadolinium contrast injection, which vi-
sualizes localized increases in extracellular volume
and has become commonplace for myocardial scar
imaging, T1 mapping does not require focal differ-
ences and thus allows quantiﬁcation of diffuse my-
ocardial changes such as nonfocal edema or ﬁbrosis.
T1 mapping of extracellular volume gives no speciﬁc
information why the extracellular space is increased
and what kind of material ﬁlls it—it only measures the
fraction of the total myocardial volume that is extra-
cellular. In a small series of post–heart transplantFIGURE 11 Determination of ECV Fraction by T1 Imaging With
Contrast Cardiac Magnetic Resonance
T1-based extracellular volume map in which signal intensity is
proportional to extracellular volume fraction (the percentage of
total tissue volume that is extracellular). The map was calculated
from T1 times before and after contrast application, and extra-
cellular volume fraction was calibrated by measuring extracel-
lular volume (ECV) in a blood sample as (1  hematocrit) (86). In
the sample region of interest in the myocardium, the average
ECV fraction was 22%.patients, a modest correlation of T1 times with the
constant of chamber stiffness was found. Impor-
tantly, in this small group of patients, there was no
signiﬁcant relation of T1 relaxation times to inva-
sively measured LV diastolic pressure, the relaxation
constant tau, or near simultaneous echocardiographic
E/e0 ratio, thus cautioning against a too simplistic
equation between T1 times and diastolic function
(88). In another study comparing patients with heart
failure with reduced or preserved ejection fraction
with control patients, patients with HFpEF had larger
extracellular volume fractions (29%) than control
patients (27%) but smaller than patients with reduced
ejection fraction (31%); however, the differences
were very small (89). Another study found a weak
correlation of the E/e0 ratio with myocardial T1 times
after contrast application and in a small subgroup
with myocardial biopsy, a good inverse correlation
between T1 time after contrast application and
extracellular volume fraction (90). Thus, there are
conﬂicting results for T1-related techniques, ﬁbrosis,
and diastolic function. The technique still has to
be considered experimental, with a clear need for
more validation and establishment of procedural and
analytical standards. Thus, although CMR techniques
at present allow the characterization of tissue to a
degree and thus allow for unique diagnostic infor-
mation, their utility for diagnosing and following
diastolic LV function remains limited and impractical.
Finally, CMR is a well-established modality for the
difﬁcult diagnosis of constrictive pericarditis, for
which it not only can directly assess pericardial thick-
ening but also help diagnose the amount of respiratory
variation in left and right ventricular ﬁlling (91).
ASSESSMENT OF DIASTOLIC FUNCTION:
CARDIAC CT
Because of radiation exposure and the availability of
other techniques for this purpose, CT has only spo-
radically been used to assess diastolic function. Similar
to nuclear imaging and CMR, it provides LV volume
data, albeit at a modest temporal resolution. An im-
portant application of CT is the detailedmorphological
diagnosis of constrictive pericarditis.
ROLE OF AGE AND PHYSICAL EXERCISE FOR
THE LIMITS OF NORMALCY
A vexing question is the extent to which age-related
changes in diastolic function, and their correlates on
imaging, are truly related to aging and thus unavoid-
able and which changes are due to modiﬁable factors.
The relaxation constant tau has been found by some
(92), but not all (93), investigators to increase with age.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 9 , 2 0 1 5 Flachskampf et al.
S E P T E M B E R 2 0 1 5 : 1 0 7 1 – 9 3 Cardiac Imaging for LV Diastolic Function
1089LV chamber stiffness, the inverse of LV compliance,
increases with age in sedentary, but not in highly
endurance-trained, individuals (94). Therefore, it
is not clear how much of the changes observed in
diastolic imaging parameters in older adults (e.g.,
decreased transmitral E/A ratio) are due to aging alone
and how much is caused by either diseases, such as
hypertension, or physical deconditioning (“sedentary
lifestyle”). It may well be that aging plays a relatively
modest role in the changes observed in elderly in-
dividuals. For example, higher transmitral peak E/A
ratios have been found in athletes than in sedentary
individuals of the same age, particularly in older
adults (95–98). A study of nearly 3,000 middle-aged
individuals participating in a ﬁtness program (98)
found these effects not only in high-level athletes but
also in less trained individuals. Individualswith higher
exercise capacity had less concentric LV remodeling
(but higher LV mass in men), smaller relative wall
thickness, lower E/e0 ratios, and higher E/A ratios than
less ﬁt individuals. Interestingly, LA and LV size
increased with exercise capacity, indicating that it is
not unambiguously related to diastolic function.
Ejection fraction, on the other hand, was not related to
exercise capacity. Several trials have shown positive
effects of exercise training on patients with HFpEF
and indirectly demonstrated improved diastolic func-
tion (99–101).
An important question is what signiﬁcance imaging
signs of diastolic dysfunction have in patients
without clear-cut symptoms. This situation has been
termed pre-clinical diastolic dysfunction, a suggestive
name in need of objective evidence from longitudinal
studies. Several large studies have suggested that
even mild diastolic abnormalities in the presence of
preserved LV ejection fraction imply an impaired
prognosis independently from age and baseline
symptoms (102–104). On the other hand, population-
based studies have shown a high prevalence of
asymptomatic diastolic dysfunction based on echo-
cardiographic parameters. Abhayaratna et al. (105)
showed that in an Australian population aged $60
years with preserved ejection fraction, 23.5% had
mild and 5.6% had moderate or severe diastolic dys-
function by echocardiography; even of the latter
group, 36% were asymptomatic. In contrast, only
0.5% of the group with reduced ejection fraction was
asymptomatic. Similar numbers have been reported
from the Framingham Heart Study in the United
States (106), with 36% of elderly participants having
asymptomatic diastolic dysfunction and 5% asymp-
tomatic systolic dysfunction. From Italy, similar
values for silent diastolic dysfunction (35% of a pop-
ulation 65 to 84 years old), again far more thanfor systolic dysfunction, have been documented
(107). A retrospective study following patients who at
baseline had moderate or severe diastolic dysfunction
on echocardiography, but no heart failure symptoms,
showed that only 12% went on to develop overt heart
failure over the next 3 years (108). However, in pa-
tients with diabetes, asymptomatic diastolic dys-
function and, in particular, E/e0 ratio >15 (septal e0)
have been shown to predict more than a doubling of
the rate of overt heart failure over the next 5 years
(109,110).
OPEN QUESTIONS AND UNMET NEEDS
There continue to be large gaps in our understanding
of diastolic heart failure, and delayed relaxation,
reduced compliance, and atrial dysfunction may have
very separate causes and yet all produce the clinical
syndrome of diastolic dysfunction. Further, whether
this condition is due to a speciﬁc myocardial disease
or results from a myocardial response to unfavorable
working conditions, in particular arterial stiffening,
remains unclear.
The issue of diastolic function grading remains hotly
debated. A large observational study reported that
patients frequently (17% of patients examined at a
clinical echocardiography laboratory) had intermedi-
ate features between grades 1 and 2 (E/A ratio #0.75,
deceleration time>140ms, and E/e0 ratio$10) and had
a distinctly worse prognosis than those with classic
grade 1 dysfunction (differing in that E/e0 ratio #8),
which was similar to the prognosis of grade 2 dys-
function (111). This classiﬁcation purports to reﬂect
different severities and advancement of diastolic
dysfunction, and for some diseases, like amyloidosis,
this has been convincingly shown (112). However, it is
based on echocardiographic patterns and thus indirect
signs of elevated diastolic LV pressures, not any spe-
ciﬁc disease pathology. It is also unclear whether
the existing stages are optimal for clinical use. An
additional subdivision of stage 1 (deﬁned by E/A
ratio #0.75, deceleration time >140 ms, and E/e0
ratio <10) has been suggested, with the same limits for
E/A ratio and deceleration time but E/e0 ratio $10 (111).
Others have proposed to add reversibility of stage 3
after therapy as a stratifying criterion. More epidemi-
ological data are needed to better understand the
clinical and prognostic value and perhaps to modify
this classiﬁcation.
Mitral regurgitation considerably complicates the
interpretation of imaging data with regard to LV
diastolic function: it elevates diastolic pressures in
the LA and LV, causes chronic dilation of the LA, in-
creases pulmonary capillary pressure and pulmonary
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failure. Most of the routinely evaluated parameters of
diastolic function, such as transmitral and pulmonary
venous ﬂow patterns, E/e0 ratio, systolic pulmonary
pressure, LA size, and others, are affected by mitral
regurgitation indistinguishably from primarily LV
myocardial dysfunction. In the presence of gross
morphological abnormalities of the mitral valve (e.g.,
a ﬂail leaﬂet), the differential diagnosis is relatively
easy; however, this is not the case in functional mitral
regurgitation, and separation of valvular and
myocardial etiology is particularly difﬁcult in patients
with atrial ﬁbrillation and degenerative valvular
changes like annular calciﬁcation, among other
conditions.No established drug or other therapy for HFpEF
exists, perhaps with the exception of physical exercise
training. Given the heterogeneity of HFpEF pop-
ulations, it may well be that only targeted therapies
(113), addressing speciﬁc subgroups of such patients,
will be successful. This underscores the need of “deep
phenotyping” these patients, a task for which cardiac
imaging with its ever more differentiated, multi-
pronged armamentarium appears well suited.
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